AACR Annual Meeting 2017

April 1-5, 2017

Washington, USA
Participants: Juergen Gamer, PhD, VP Business Development 
Christian Gieffers, PhD, VP Analytics / Protein Chemistry
Christian Merz, PhD, Head of Cellular Analytics
Meinolf Thiemann, PhD, Director Assay Development

  • Talk on  April 04, 15:05 - 15:20 pm (Abstract Nr. 4963): "Novel hexavalent GITR agonists stimulate T cells and enhance memory formation"
  • Poster (Abstract Nr. 4690 / 6): "Hexavalent CD27 agonists show single agent anti-tumor activity and enhanced memory formation in mouse syngeneic tumor models"
  • Poster (Abstract Nr. 1688 / 7): "HERA-CD40L: A novel hexavalent CD40 agonist with superior biological activity"


Future Leaders in Biotechnology

April 7, 2017

New York, USA
Participant: Thomas Höger, PhD, CEO
Talk: 09:30 - 09:55

 

The 14th International Symposium on Myelodysplastic Syndromes

Mai 3-6,  2017

Valencia, Spain
Participants: Claudia Kunz, PhD, Director Clinical Development
Alexandra Pinczolits, PhD, Clinical Project Manager
 

 

2nd EACR-AACR-SIC Special Conference:
The Challenges of Optimising Immuno and Targeted Therapies

June 24 - 27, 2017

Florence, Italy
Participants:  Meinolf Thiemann, PhD, Director Assay Development
June 25th, 2017, Posterpresentation: "Hexavalent CD27 agonists show single agent anti-tumor activity in mouse
syngeneic tumor models which is augmented by combination with anti-PD-1"